ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 7 May 2008. doi:10.1136/adc.2007.125237
Archives of Disease in Childhood 2008;93:725-727
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
adc.2007.125237v1
93/9/725    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Peet, A. C
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peet, A. C

Leading articles

The value of magnetic resonance spectroscopy in tumour imaging

Andrew C Peet1,2, Theodoros N Arvanitis2,3, Dorothee P Auer4, Nigel P Davies1,5, Darren Hargrave6, Franklyn A Howe7, Tim Jaspan8, Martin O Leach9, Donald Macarthur8, Lesley MacPherson2, Paul S Morgan4, Kal Natarajan1,5, Geoffrey S Payne9, Dawn Saunders10, Richard G Grundy11, CCLG Functional Imaging Group

1 Academic Paediatrics and Child Health, University of Birmingham, UK
2 Birmingham Children’s Hospital Foundation Trust, UK
3 Electrical, Electronic and Computer Engineering, University of Birmingham, UK
4 Academic Radiology, Nottingham University Hospitals, UK
5 Medical Physics and Imaging, University Hospital Birmingham Foundation Trust, UK
6 Royal Marsden Hospital Foundation Trust, UK
7 St George’s, University of London, UK
8 Nottingham University Hospitals, Nottingham, UK
9 Institute of Cancer Research, Sutton, UK
10 Great Ormond Street Hospital for Sick Children, London, UK
11 Children’s Brain Tumour Research Centre, Nottingham University Hospitals, Nottingham, UK

Correspondence to:
Andrew Peet, Chair CCLG Functional Imaging Group, Academic Paediatrics and Child Health, Whittall Street, Birmingham B4 6NH, UK; acpeet@doctors.org.uk

Accepted for publication 23 April 2008

The first 150 words of the full text of this article appear below.

Magnetic resonance (MR) imaging has a key role in the management of many childhood tumours. There is increasing interest in extending these investigations to MR techniques that give information on tumour biology in vivo. Magnetic resonance spectroscopy (MRS) is one such method and it provides information on tissue biochemistry. Promising results have been obtained from many preclinical and clinical studies, leading to an expectation that MRS will play a valuable clinical role. However, the role of MRS is not yet well defined and there is a paucity of data from multi-centre clinical trials. In this article we concentrate on MRS in paediatric oncology and provide some general guidance on current applications and outline areas that need to be developed further.


MRS FUNDAMENTALS, DATA ACQUISITION AND ANALYSIS
Certain atomic nuclei (eg, 1H, 31P and 13C) possess a magnetic moment and when placed in a strong magnetic field will resonate at a particular radiofrequency that subtly depends . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health